Följ oss
the_ad_group(12516);

Nyheter

Investing in the biggest security story of our time

Publicerad

den

Cyber security: Investing in the biggest security story of our time. Cyber security has become a top priority for companies and governments worldwide and it’s easy

Cyber security: Investing in the biggest security story of our time. Cyber security has become a top priority for companies and governments worldwide and it’s easy to see why: the move to digital means that businesses have a greater reliance than ever on the internet for a huge array of functions. And can be seen from the almost daily reports of security breaches and high profile attacks, no individuals, businesses or even governments are safe. In the last year alone, we have witnessed cyber attacks on organisations of every kind, from US political parties to UK mobile phone operators.

Senior executives, rather than back-office IT teams, now have ultimate responsibility for protecting networks, data and internet-enabled devices. As a result, cyber security has become big business: an estimated $1 trillion globally will be spent on cyber security products and services between 2017 and 2021. The risk of cyber attacks has also been heightened by the growing number of internet-connected devices globally. It is expected that 200 billion smart devices will be in use by 2020.

With cyber security now a megatrend, how can investors access this growing sector?

What is cyber security?

First and foremost, the cyber security industry is not a single discipline – it involves the expertise of companies in a range of sectors, including software development, communications equipment, advisory firms and aerospace and defence companies. There is no single way companies can keep their networks, devices and data secure: training staff to look out for bogus emails is as important as keeping software up to date and encrypting the most sensitive data.

The overall goal of cyber security is to protect computer networks, programs, connected devices such as desktop computers and smartphones, and the data they hold, from unauthorised access and theft. This could be a deliberate and/or malicious attack by a cyber criminal looking to steal data to sell, a hacker looking to cause mischief or a business rival or nation state looking for sensitive information. It could also be an innocent mistake; 17.7 per cent of data breaches were caused by unintentional actions or errors, according to 2016 research by Verizon.

The cyber threat is real – and companies are spending money to tackle it

One of the unique aspects of cyber security is that cyber threats are constantly evolving: as systems and devices evolve, would-be attackers are developing loopholes to exploit them. The number of cyber threats affecting businesses reached an all-time high in 2016, including a 752 per cent jump in the varieties of ransomware seen by security experts, according to Trend Micro research.

High-profile cyber attacks are illustrative of the potential damage cyber attacks can have on a company’s reputation, revenue and future growth prospects. Yahoo last year disclosed two breaches, one affecting more than 1 billion accounts and the second around 500 million users.5 These breaches resulted in US criminal charges and caused Verizon to abandon its takeover bid of Yahoo for $350 million. In the UK, internet service provider TalkTalk had to pay a record £400,000 fine after the personal details of 150,000 customers were accessed by a cyber-attack. In the political sphere, it is alleged that Russian hackers targeted senior Democratic party figures as part of efforts to influence the outcome of last year’s US presidential election.

IDC forecasts a compound annual growth rate (CAGR) of 8.3 per cent for the cyber security industry, more than twice the rate of overall IT spending growth, between 2016 and 20207. Within cyber security, the largest areas of growth will be mobile security, Internet of Things (IoT) security, and specialised threat analysis and protection, according to Bloomberg and IDC.

How can investors access the cyber security megatrend?

Cyber security, and the organisations and products that companies use to combat the threat, will become increasingly important: regulatory requirements on data protection and privacy are set to increase, and the expansion of the Internet of Things means more objects, from phones to fridges, will have an internet connection and produce data that will need to be secured.

Governments are also making it a priority: Philip Hammond, UK Chancellor of the Exchequer, has set up the National Cyber Security Strategy, underpinned by a £1.9 billion investment, and President Trump in the US is expected to sign an executive order on cyber security in the spring.

All these elements mean businesses are likely to allocate bigger budgets to cyber security. However it is too early in the life of the cyber security megatrend to clearly identify any winners: there are many competing technologies addressing the ever-evolving threat, including the work of start-ups that haven’t yet secured patents. These smaller companies are offering innovative technologies and products, and venture capital firms invested around $8 billion in cyber security companies between 2014 and 2016. Additionally, trying to pick individual stocks among companies at such an early stage exposes investors to a higher degree of volatility than they may wish to take on.

Investment exposure to the cyber security industry therefore requires a passive approach. A global and diversified exposure can give investors access to all the elements spurring growth of the cyber security space. Typically, smaller and midcap companies have been offering the most innovative technologies and products, and so any exposure should ideally capture these players. Finally, in order to remain true to the theme, an equal-weight portfolio ensures end-to-end exposure to the whole ecosystem of companies and provides exposure to the companies that will be tomorrow’s winners.

For more information, visit etfsecurities.com/cyber

Important Information

This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (“ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). While this communication is made by ETFS UK, certain content has been produced and provided for ETFS UK by ROBO Global Partners Ltd. (“ROBO Global®”). ROBO Global® is an independent, unaffiliated third party to ETFS UK. No forwarding, reprinting, republication or any other redistribution of this content is permissible without the express consent of ROBO Global® and ETFS UK. ROBO Global® and ETFS UK reserve the right to enforce their respective copyrights and pursue any such other action as they deem appropriate in respect of any such unauthorised use, republication or redistribution of this communication.

The information contained in this communication is for your general information only and is neither an offer for sale nor a solicitation of an offer to buy securities. This communication should not be used as the basis for any investment decision. Historical performance is not an indication of future performance and any investments may go down in value.

This document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of shares or securities in the United States or any province or territory thereof. Neither this document nor any copy hereof should be taken, transmitted or distributed (directly or indirectly) into the United States.

This communication may contain independent market commentary prepared by ETFS UK based on publicly available information. Although ETFS UK endeavours to ensure the accuracy of the content in this communication, ETFS UK does not warrant or guarantee its accuracy or correctness. Any third party data providers used to source the information in this communication make no warranties or representation of any kind relating to such data. Where ETFS UK has expressed its own opinions related to product or market activity, these views may change. Neither ETFS UK, nor any affiliate, nor any of their respective officers, directors, partners, or employees accepts any liability whatsoever for any direct or consequential loss arising from any use of this publication or its contents.

ETFS UK is required by the FCA to clarify that it is not acting for you in any way in relation to the investment or investment activity to which this communication relates. In particular, ETFS UK will not provide any investment services to you and or advise you on the merits of, or make any recommendation to you in relation to, the terms of any transaction. No representative of ETFS UK is authorised to behave in any way which would lead you to believe otherwise. ETFS UK is not, therefore, responsible for providing you with the protections afforded to its clients and you should seek your own independent legal, investment and tax or other advice as you see fit.

Fortsätt läsa
Annons
Klicka för att kommentera

Skriv en kommentar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *

Nyheter

Fem börshandlade fonder för investeringar i healthcare : Den stora möjligheten 2025?

Publicerad

den

Året för investeringar i healthcare har varit blygsamt. Men när man ser hur marknaden går i år kan man säga att de "håller sig". Under det första kvartalet 2025 uppvisade MSCI World Index, som mäter utvecklingen för stora och medelstora aktier i 23 utvecklade länder, en blygsam genomsnittlig avkastning på 2,57 %.

Året för investeringar i healthcare har varit blygsamt. Men när man ser hur marknaden går i år kan man säga att de ”håller sig”. Under det första kvartalet 2025 uppvisade MSCI World Index, som mäter utvecklingen för stora och medelstora aktier i 23 utvecklade länder, en blygsam genomsnittlig avkastning på 2,57 %.

Med tanke på ödet för vissa andra sektorer, såsom teknik, i detta sammanhang av osäkerhet som drivs av Donald Trumps ankomst till Vita huset, kan det till och med vara positivt. ”Hälsovårdssektorn har återigen visat sin defensiva karaktär i en osäker miljö. Hittills under 2025 har stora läkemedelsföretag etablerat sig som marknadsvinnare, medan bioteknikföretag står inför flera utmaningar”, kommenterade DNB AM nyligen.

Förra året släpade sektorn även efter andra sektorer i den globala ekonomin. Detta minskade dess representation i MSCI World Index till 10,7 %, den lägsta nivån på mer än ett decennium.

Men experter insisterar: branschvärderingar är mycket attraktiva, så vi kan stå inför en stor marknadsmöjlighet. ”De utomordentligt låga värderingar vi för närvarande har pekar på undervärderad vitalitet som kan erbjuda intressanta instegspunkter”, kommenterade Vinay Thapar, co-chief investment officer och senior analysanalytiker på Alliance Bernstein, nyligen.

Resultatet är en ”solid outlook” som kan erbjuda möjligheter till investerare som söker tillväxtpotential och ”historiskt attraktiva” priser. Vidare lyfter han fram den defensiva karaktären hos dessa företag, som kan fungera som en defensiv motvikt i portföljer, ”särskilt om inflationen och räntorna förblir höga under längre tid.”

Den stora möjligheten 2025?

Hälso- och sjukvård är ett ämne som omfattar mycket mer än en enskild sektor, som omfattar olika specialiteter: från läkemedelstillverkare till tillverkare av sjukhusutrustning, inklusive bioteknik och cancerforskning.

Nedan finns fem aktie-ETFer inom hälsosektorn, rankade från lägsta till högsta årliga avkastning under en treårsperiod.

iShares Aging Population UCITS ETF USD (Acc)

BlackRocks iShares Aging Population Index försöker följa resultatet för iSTOXX FactSet Aging Population Index, som inkluderar globala företag som genererar betydande intäkter från att tillhandahålla varor och tjänster till en åldrande befolkning.

Med tillgångar på 372,1 miljoner euro har denna ETF sett en avkastningsminskning på -1,01 % 2025. Dess treåriga årliga avkastning är dock 4,05 %. Dess toppinnehav inkluderar Robinhood Markets, Intra-Cellular Therapies, BeiGene Ltd, Exelixis och Unum Group, alla med vikter nära 0,8% till 0,9% av portföljen. Det fångar möjligheter inom olika segment som bioteknik, försäkringar etc., allt kopplat till tillväxten av seniorbefolkningen.

Xtrackers MSCI USA Health Care UCITS ETF 1D

Xtrackers MSCI USA Health Care UCITS ETF följer MSCI USA Health Care Index, som består av amerikanska hälsovårdsföretag med stora och medelstora företag. Med tillgångar på 630,2 miljoner euro har denna ETF haft en avkastning på 1,62 % 2025 och en årlig avkastning på 4,46 % över tre år.

Dess portfölj domineras av färre företag än den tidigare ETFen, av tungviktare som Eli Lilly (12,23 %), UnitedHealth Group (8,38 %), Johnson & Johnson (7,10 %), AbbVie (6,79 %) och Merck & Co (4,31 %). Dessa bolag står för mer än en tredjedel av fondens totala portfölj, vilket visar dess kapitaliseringsviktade fokus på etablerade industriledare.

Invesco Health Care S&P US Select Sector UCITS ETF

Invesco Health Care S&P US Select Sector UCITS ETF syftar till att spåra resultatet för S&P Select Sector Capped 20% Health Care Index, som representerar hälso- och sjukvårdssektorn i S&P 500. Med tillgångar på 400,5 miljoner euro, har denna ETF en avkastning på 3-2,0 % per år. 4,55 %.

Den börshandlade fonden investerar genom en TRS (Total Return Swap) på S&P Select Sector Capped 20% Health Care Index. Detta innebär att det använder ett finansiellt derivat som gör att det kan replikera indexets lönsamhet till 100 %, utan att fysiskt behöva köpa värdepapperen.

För att undvika överdriven koncentration i ett enskilt företag föreskriver indexet att inget företag får ha en vikt större än 19 %. Om något företag överskrider denna gräns omfördelas överskottet mellan de andra företagen i indexet.

Några av de stora företagen som vanligtvis ingår i detta index inkluderar Johnson & Johnson, Pfizer, Merck & Co., UnitedHealth Group och Abbott Laboratories.

SPDR S&P U.S. Health Care Select Sector UCITS ETF

Denna ETF, SPDR S&P U.S. Health Care Select Sector UCITS ETF, som förvaltas av State Street Global Advisors, följer S&P Health Care Select Sector Index, som grupperar de ledande hälsovårdsaktierna inom S&P 500, inklusive stora läkemedelsföretag, sjukförsäkringsbolag och tillverkare av medicinsk utrustning. Med tillgångar på 355,6 miljoner euro uppnådde detta börsnoterade företag en avkastning på 2,01 %, medan dess treåriga årliga avkastning är 4,56 %.

Den har en liknande sammansättning som Invesco ETF, men utan gränsen på 19 %. De högsta innehaven är Eli Lilly (13,31 %), UnitedHealth Group (8,02 %), Johnson & Johnson (7,29 %), AbbVie (6,78 %) och Abbott Laboratories (4,39 %). Dessa företag representerar nästan 40 % av den totala fonden.

Amundi STOXX Europe 600 Healthcare UCITS ETF Acc

Denna Amundi ETF, Amundi STOXX Europe 600 Healthcare UCITS ETF Acc, är den enda på listan som fokuserar på den europeiska marknaden. Det replikerar STOXX Europe 600 Health Care, ett index som samlar kontinentens ledande hälsovårdsföretag, inklusive läkemedels-, bioteknik- och medicintekniska tillverkare. Med tillgångar på 797 miljoner euro är det också den största fonden i rankingen (även om den inte är den största i kategorin: det skulle vara Xtrackers MSCI World Health Care med mer än 2,6 miljarder dollar).

Även om lönsamheten 2025 är mer blygsam (+0,64%), sticker den tydligt ut när man analyserar dess långsiktiga resultat: med en 3-årig årlig avkastning på 7,31%, rankas den som den mest lönsamma ETFen i hälsovårdssektorn över 3 år inom sin kategori.

Dess portfölj är starkt koncentrerad till en handfull stora aktier i sektorn. De fem största positionerna är Roche (13,41%), AstraZeneca (13,09%), Novartis (12,67%), Novo Nordisk (12,61%) och Sanofi (7,52%), som tillsammans står för nästan 60% av den totala portföljen.

Dessutom inkluderar de tio bästa innehaven även kända namn som EssilorLuxottica (5,16 %), GSK (4,73 %) och Alcon (2,73 %).

När man väljer en ETF som ger exponering mot healthcare bör man överväga flera andra faktorer utöver metodiken för det underliggande indexet och prestanda för en ETF. För ytterligare information om respektive börshandlad fond, klicka på kortnamnet i tabellen nedan.

Börshandlade fonder för investeringar i healthcare : Den stora möjligheten 2025?

Alla dessa börshandlade fonder utom Invesco Health Care S&P US Select Sector UCITS ETF handlas på tyska Xetra. Invesco Health Care S&P US Select Sector UCITS ETFandlas på London Stock Exchange.

Det betyder att det går att handla andelar i dessa ETFer genom de flesta svenska banker och Internetmäklare, till exempel  NordnetSAVRDEGIRO och Avanza.

NamnUtveckling
Innevarande år
Utveckling
Tre år
AUM
Amundi STOXX Europe 600 Healthcare UCITS ETF0,64%7,31%797,0M€
SPDR S&P U.S. Health Care Select Sector UCITS ETF2,01%4,56%355,6M€
Invesco Health Care S&P US Select Sector UCITS ETF2,03%4,55%400,5M€
Xtrackers MSCI USA Health Care UCITS ETF1,62%4,46%630,2M€
iShares Ageing Population UCITS ETF-1,01%4,05%372,1M€

Detta innehåll har utarbetats under redaktionella kriterier och utgör ingen rekommendation eller investeringsförslag. Att investera innehåller risker. Tidigare resultat är ingen garanti för framtida resultat.

Fortsätt läsa

Nyheter

S5EW ETF är en likaviktad satsning på S&P500

Publicerad

den

UBS ETF (IE) S&P 500 Equal Weight SF UCITS ETF (USD) A-dis (S5EW ETF) med ISIN IE000OAZZ3X6, försöker följa S&P 500® Equal Weight-index. S&P 500® Equal Weight (EWI)-index följer stora amerikanska aktier med lika vikt och fast vikt på 0,20 %.

UBS ETF (IE) S&P 500 Equal Weight SF UCITS ETF (USD) A-dis (S5EW ETF) med ISIN IE000OAZZ3X6, försöker följa S&P 500® Equal Weight-index. S&P 500® Equal Weight (EWI)-index följer stora amerikanska aktier med lika vikt och fast vikt på 0,20 %.

Den börshandlade fondens TER (total cost ratio) uppgår till 0,12 % p.a. UBS ETF (IE) S&P 500 Equal Weight SF UCITS ETF (USD) A-dis är den billigaste ETF som följer S&P 500® Equal Weight-index. ETFen replikerar resultatet för det underliggande indexet syntetiskt med en swap. Utdelningarna i ETFen delas ut till investerarna (halvårsvis).

ETFen lanserades den 20 februari 2025 och har sin hemvist i Irland.

Översikt

Investeringsmålet är att replikera resultatet för S&P 500 Equal Weight Index.

Fonden replikerar syntetiskt indexutvecklingen genom att investera i en swap.

Swapmotparten överför säkerheter till ETFen i form av G10-statsobligationer, överstatliga obligationer och kontanter.

Fördelar

Kunder drar nytta av flexibiliteten hos en börshandlad investering och investerarskyddet som en fond erbjuder.

Ger tillgång till detta segment av marknaden med en enda transaktion.

Optimerad risk/avkastningsprofil tack vare en bred diversifiering över en rad sektorer.

Fonden erbjuder en hög grad av transparens och kostnadseffektivitet och är lätt att handla.

UCITS-kompatibel fond.

Handla S5EW ETF

UBS ETF (IE) S&P 500 Equal Weight SF UCITS ETF (USD) A-dis (S5EW ETF) är en europeisk börshandlad produkt som handlas på London Stock Exchange.

London Stock Exchange är marknader som få svenska banker och nätmäklare erbjuder access till, men DEGIRO gör det.

Börsnoteringar

BörsValutaKortnamn
London Stock ExchangeGBXS5EW

Fortsätt läsa

Nyheter

Spotlight on the tariff war

Publicerad

den

The impact of US tariffs continues to dominate market sentiment and risk assets, including crypto, struggled with this uncertainty throughout the month. The Nasdaq Crypto Index™ (NCI™) fell 4.46% in March as the S&P 500 and Nasdaq 100 dropped 5.63% and 7.61%, respectively.

The impact of US tariffs continues to dominate market sentiment and risk assets, including crypto, struggled with this uncertainty throughout the month. The Nasdaq Crypto Index™ (NCI™) fell 4.46% in March as the S&P 500 and Nasdaq 100 dropped 5.63% and 7.61%, respectively.

Despite the macro uncertainty from Washington, US policymakers are continuing to embrace crypto in an unprecedented way, including launching a Bitcoin Strategic Reserve, Digital Asset Stockpile, and engaging in expansive work at the regulatory agencies and in Congress.

Our team spent the last week of the month in Washington, meeting with regulators to share our experiences and views on what’s most important for crypto investors in the US. In his latest Notes from the CIO, Samir Kerbage shares what he learned from these meetings and how investors should be thinking about the new regulatory regime in the US.

As always, we are greatly appreciative of your trust in us and are here to answer any questions you may have.

-Your Partners at Hashdex

Market Review

March was marked by the tariff dispute triggered by the Trump administration. Back-and-forth fiscal policies, threats, and retaliations dominated the month’s agenda. The uncertain macroeconomic environment put investors into a defensive stance and negatively impacted crypto assets. The Nasdaq Crypto Index™ (NCI™) closed the month down -4.46% after a period of high volatility. Major market indices, the S&P 500 and Nasdaq-100, also recorded steep declines of -5.63% and -7.61%, respectively. These concurrent drawdowns across equities and crypto underscored March’s broad market caution, as trade war uncertainty prompted investors to flee risk assets.

During times of uncertainty, it is common to observe increased correlation among different classes of risk assets. This pattern played out in March: the 6-month rolling correlation of monthly returns between the NCI™ and the Nasdaq-100 surged to roughly 0.91 (see chart below), its highest level since 2021, indicating that crypto assets were moving almost in lockstep with tech stocks. This spike in correlation confirms that crypto was behaving like a high-beta extension of the tech sector—an amplified version of the Nasdaq-100. The lack of clarity in the global landscape leads investors to reduce their risk exposure and seek protection, a movement known in financial markets as “risk-off” allocation.

6-Month Rolling Correlation of Monthly Returns between the Nasdaq Crypto Index and Nasdaq-100 (Apr 2021–Apr 2025).

The chart illustrates how this correlation has been increasing since the American elections in November 2024 and spiked to approximately 0.91 in the most recent period—a multi-year high. This visual evidence reinforces the view that crypto assets have been moving closely in tandem with tech stocks, effectively acting as a high-beta version of the Nasdaq-100 during the March risk-off phase.

Following this trend, risk reduction was evident within the crypto asset class. Among the NCI’s constituents, Bitcoin (BTC) posted a decline of -1.93%, withstanding the downturn far better than other constituents such as Ether (ETH, -17.4%) and Litecoin (LTC, -34.6%). BTC’s relatively mild drop in this sell-off aligns with the idea that it increasingly trades like a high-beta proxy for large-cap tech. It still declined, but less severely, whereas smaller-cap crypto assets behaved more like speculative growth stocks and suffered outsized losses. The only exception to the negative results was Cardano (ADA), which surprised with a positive return of 3.88% despite no significant protocol developments during the month.

Thematic indices also faced a challenging environment. As highlighted in previous letters, smaller capitalization assets tend to suffer more during periods of market stress, mirroring how speculative small-cap stocks are hit hardest in equity sell-offs. The biggest negative highlight was the Digital Culture Index, which dropped -17.45%, followed by the Decentralized Finance (DeFi) and Smart Contract Platform (Web3) indices, which fell -16.73% and -12.07%, respectively. The Vinter Hashdex Risk Parity Momentum Index recorded a negative result of -8.26% but outperformed the three other thematic indices, benefiting from its high allocation in BTC and TRX (which gained 4.68%). The heavy weighting in BTC – the more resilient large-cap crypto – helped cushion this index, underscoring the relevance of the momentum factor in a well-diversified strategy during times of market stress.

The market remains on the lookout for the outcome of the fiscal policy discussions, hoping for a reduction in uncertainties and an end to the tariff war. That would likely mark the moment when investors regain their appetite for risk assets, including crypto assets. The U.S. government has also signaled interest in advancing the crypto agenda, a development that could drive the asset class to a new level of adoption. We remain confident in our positive outlook for the rest of the year and the long term.

Top Stories

US creates Bitcoin Strategic Reserve and Digital Asset Stockpile

The Bitcoin Reserve will be capitalized with BTC owned by the Department of Treasury, which could further increase via new budget-neutral acquisitions. The stockpile will also include assets owned by the Treasury. This marks a major milestone, with the US government starting to integrate major crypto assets and continues the new administration’s work to lead the global crypto economy.

Stablecoins surpass $230 billion in market value

The total stablecoins market capitalization surpassed $230 billion amid institutional demand for dollar-backed digital assets. This showcases one of the most successful applications for crypto technology enhancing traditional financial payments. It could also pave the way for new use cases that require a strong and reliable global payment system.

FDIC eases banks’ ability to engage in crypto activities

The FDIC has rescinded previous guidelines which prevented financial institutions from engaging with crypto activities without prior sign-off. By removing bureaucratic hurdles, banks may more readily over crypto-related services, potentially leading to broader adoption and integration of digital assets into the financial system.


Fortsätt läsa

21Shares

Prenumerera på nyheter om ETFer

* indicates required

21Shares

Populära